The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of daratumumab (DARA) monotherapy in patients with ≥ 3 lines of prior therapy or double refractory multiple myeloma (MM): 54767414MMY2002 (Sirius).
 
Sagar Lonial
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Millennium; Novartis; Onyx
 
Brendan M. Weiss
Consulting or Advisory Role - Janssen; Millennium
Research Funding - Janssen; Onclave Therapeutics
 
Saad Zafar Usmani
Consulting or Advisory Role - Celgene; Millennium; Onyx; Sanofi
Speakers' Bureau - Celgene; Millennium; Onyx
Research Funding - Array BioPharma; Celgene; Janssen Oncology; Millennium; Onyx; Pharmacyclics
 
Seema Singhal
Stock and Other Ownership Interests - Celgene; Celldex; eHealth; Epizyme; Foundation Medicine; Geron; GlaxoSmithKline; ImmunoGen; Nanosphere; Panther Biotechnology; Pfizer; Pharmacyclics; Sarepta Therapeutics; Seagen; Signal Genetics; Synta; Vertex
Speakers' Bureau - Celgene; Takeda
 
Ajai Chari
Consulting or Advisory Role - Array Biopharma; Celgene; Millennium; Novartis
Research Funding - Acetylon Pharmaceuticals (Inst); Array BioPharma; Biotest (Inst); Celgene; Janssen; Millennium; Novartis; Onyx; Pharmacyclics
 
Nizar J. Bahlis
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Celgene; Johnson & Johnson
Speakers' Bureau - Celgene; Johnson & Johnson
Research Funding - Celgene; Johnson & Johnson
 
Andrew Belch
Consulting or Advisory Role - Amgen; Celgene; Janssen
 
Amrita Y. Krishnan
Stock and Other Ownership Interests - Array BioPharma (I); Celgene (I); Infinity Pharmaceuticals (I); Pharmacyclics (I)
Consulting or Advisory Role - Celgene; Onyx; Spectrum Pharmaceuticals
Speakers' Bureau - Celgene; Genentech; millennium; onyx
 
Robert A. Vescio
Speakers' Bureau - Celgene; Millennium; Onyx; Takeda
 
María-Victoria Mateos
Honoraria - Celgene; Janssen-Cilag
Consulting or Advisory Role - Celgene; Janssen-Cilag; Onyx; Takeda
 
Amitabha Mazumder
Speakers' Bureau - Celgene; Millennium; Onyx
 
Robert Z. Orlowski
Consulting or Advisory Role - Acetylon Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx
Research Funding - Array BioPharma; Bristol-Myers Squibb; Celgene; Millennium; Onyx; Spectrum Pharmaceuticals
 
Heather J Sutherland
Honoraria - Celgene; Janssen
Consulting or Advisory Role - Celgene; Janssen
Research Funding - GlaxoSmithKline; Janssen; Novartis
 
Joan Blade
Honoraria - Binding Site; Celgene; Janssen; Onyx
Research Funding - Janssen
 
Emma Catherine Scott
Consulting or Advisory Role - Millennium; Onyx
Speakers' Bureau - Millennium
Research Funding - Millennium; Onyx
 
Huaibao Feng
Employment - Janssen Research & Development
 
Imran Khan
Employment - Janssen Research & Development
 
Clarissa M. Uhlar
Employment - Janssen Research & Development
 
Tahamtan Ahmadi
Employment - Janssen Research & Development
 
Peter Michael Voorhees
Honoraria - Novartis; Takeda
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Oncopeptides
Research Funding - Celgene; GlaxoSmithKline; Oncopeptides